Volumen 5, Ausgabe 6 (2015)
Clinical-Trail-Methode
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Arzneimittelbewertung
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Arzneimittelbewertung
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Klinische Trail-Perspektive
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Arzneimittelbewertung
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
